News
June 1, 2022
IGM Biosciences to Present at the 2022 Jefferies Healthcare Conference
Additional Formats
May 10, 2022
IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference
Additional Formats
May 9, 2022
IGM Biosciences Announces First Quarter 2022 Financial Results and Provides Corporate Update
Additional Formats
May 6, 2022
IGM Biosciences Announces Closing of Global Collaboration Agreement with Sanofi
Additional Formats
April 6, 2022
IGM Announces Closing of $230.0 Million Public Offering
Additional Formats
March 30, 2022
IGM Announces Pricing of $200.0 Million Public Offering
Additional Formats
March 29, 2022
IGM Announces Proposed Public Offering
Additional Formats
March 29, 2022
IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Additional Formats
March 29, 2022
IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi
Additional Formats
March 29, 2022
Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology, and Inflammation Targets
Additional Formats
Displaying 1 - 10 of 13